Search - tctmd.com

Displaying 81 - 100 of 128

Sort: Relevancy | Date

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

Access Routes for Transcatheter Mitral Valve Replacement: Clinical and Technical Design Considerations

Presenter: John G. Webb, Neil E. Moat

June 16, 2017

News Conference News TVT 2017

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Michael O'Riordan

June 15, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Presentation TVT 2017

CARDIOBAND: Eligibility and Outcomes, and RCT Design

Presenter: Saibal Kar, Vinod H. Thourani

June 15, 2017

Presentation TVT 2017

CARILLON: Eligibility and Outcomes, and RCT Design

Presenter: Saibal Kar, Steven L. Goldberg, MD

June 15, 2017

Presentation TVT 2017

The Rapid Emergence of Trans-Caval TAVR: A Step-by-Step Description of Equipment and Techniques

Presenter: Adam B. Greenbaum

June 15, 2017

Presentation TVT 2017

A Description of the U.S. REFLECT Randomized Clinical Trial

Presenter: Jeffrey W. Moses

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

Presentation TVT 2016

The Sentinel US Pivotal Clinical Trial Design

Presenter: Susheel Kodali

June 17, 2016

Presentation TVT 2016

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

The Bard TRUE Balloon: Design Features and Clinical Applications

Presenter: Jeffrey J. Popma

June 17, 2016

Presentation TVT 2016

The InterValve V8 Balloon: Design Features and Clinical Applications

Presenter: Wesley R. Pedersen

June 17, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2016

Newcomers and Important Design Concepts: TAVR in the Future

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Advertisement

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Access Routes for Transcatheter Mitral Valve Replacement: Clinical and Technical Design Considerations

Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

CARDIOBAND: Eligibility and Outcomes, and RCT Design

CARILLON: Eligibility and Outcomes, and RCT Design

The Rapid Emergence of Trans-Caval TAVR: A Step-by-Step Description of Equipment and Techniques

A Description of the U.S. REFLECT Randomized Clinical Trial

Device Design Features and Findings From EU Clinical Trials

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

The Sentinel US Pivotal Clinical Trial Design

The Sentinel Dual Filter Device: Design Features and EU Clinical Trial Results

The Bard TRUE Balloon: Design Features and Clinical Applications

The InterValve V8 Balloon: Design Features and Clinical Applications

What TAVR Needs Next . . . and What It’s Getting

Newcomers and Important Design Concepts: TAVR in the Future

Study Design for the PARTNER 3 Low-Risk Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content